OrisDX Opens Early Access Program for Oro Lesion: The First Non-Invasive Salivary DNA Test for Oral Cancer Detection
OrisDX has launched an early access program for Oro Lesion, the first non-invasive salivary DNA test aimed at detecting oral cancer. Dental practices can secure priority shipment of this revolutionary molecular diagnostic test prior to its national commercial launch.
Dental Practices Can Now Secure Priority Shipment for the Revolutionary Oral Cancer Molecular Diagnostic Test Ahead of National Commercial Launch.
CHICAGO, IL, UNITED STATES, August 26, 2026 /EINPresswire.com/ — OrisDX, a pioneer in molecular salivary …